Citation tools
"N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments.." Journal of Nuclear Medicine
61.supplement 1
(2020):
581.
Web. 18 April. 2024.